NGL Fine Chem Share Price
NGL Fine Chem Share Price Today
As of 5 Jul 2026, NGL Fine Chem share price is ₹3,206.00. The stock opened at ₹2,954.90, compared to its previous close of ₹2,937.60. During today's trading session, NGL Fine Chem share price moved in the range of ₹2,954.90 to ₹3,260.00, with an average price of ₹3,107.45 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,175.50 and a high of ₹3,260.00. On the performance front, NGL Fine Chem share price has increased by 127.68% over the last six months and is up 164.94% on a year-on-year basis.
NGL Fine Chem Returns Calculator
NGL Fine Chem Shareholder Returns
NGL Fine Chem Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
NGL Fine Chem Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹368.26 | ₹338.69 | ₹278.08 | ₹317.50 |
| Other Income | ₹8.63 | ₹14.13 | ₹5.53 | ₹10.68 |
| Total Revenue | ₹376.89 | ₹352.82 | ₹283.61 | ₹328.19 |
| Total Expenses | ₹349.17 | ₹298.40 | ₹256.25 | ₹261.59 |
| Profit Before Tax | ₹27.71 | ₹54.42 | ₹27.36 | ₹66.60 |
| Tax | ₹6.59 | ₹13.10 | ₹6.87 | ₹16.70 |
| Profit After Tax | ₹21.12 | ₹41.32 | ₹20.50 | ₹49.90 |
| EPS - Basic | ₹34.19 | ₹66.88 | ₹33.18 | ₹80.77 |
| EPS - Diluted | ₹34.19 | ₹66.88 | ₹33.18 | ₹80.77 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹27.71 | ₹54.42 | ₹27.36 | ₹66.60 |
| Income before WC changes | ₹41.43 | ₹66.18 | ₹38.89 | ₹77.93 |
| Change in Assets | -₹16.36 | -₹59.03 | ₹16.05 | -₹52.27 |
| Change in Liabilities | ₹17.34 | ₹26.41 | -₹12.79 | ₹4.87 |
| Change in WC | ₹0.98 | -₹32.62 | ₹3.26 | -₹47.40 |
| Cash flow from Operations | ₹35.82 | ₹20.47 | ₹35.29 | ₹13.82 |
| Cash flow from Investing | -₹34.55 | -₹26.82 | -₹27.02 | -₹14.20 |
| Cash flow from Financing | -₹1.08 | -₹1.08 | -₹1.08 | -₹1.08 |
| Total Cash Flow | ₹0.19 | -₹7.43 | ₹7.18 | -₹1.46 |
| Cash (Start of the year) | ₹0.40 | ₹7.83 | ₹0.64 | ₹2.10 |
| Cash (End of the year) | ₹0.58 | ₹0.40 | ₹7.83 | ₹0.64 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹198.01 | ₹142.87 | ₹124.42 | ₹103.44 |
| Current Assets | ₹235.38 | ₹212.67 | ₹162.66 | ₹173.49 |
| Total Assets | ₹433.39 | ₹355.54 | ₹287.08 | ₹276.93 |
| Current Liabilities | ₹118.97 | ₹86.59 | ₹58.29 | ₹65.65 |
| Net Current Asset | ₹116.41 | ₹126.08 | ₹104.36 | ₹107.84 |
| Non-Current Liabilities | ₹31.99 | ₹6.32 | ₹6.24 | ₹8.06 |
| Equity Capital | ₹282.43 | ₹262.63 | ₹222.55 | ₹203.22 |
| Total Equity & Liabilities | ₹433.39 | ₹355.54 | ₹287.08 | ₹276.93 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹359.29 | ₹328.97 | ₹275.05 | ₹318.67 |
| Other Income | ₹9.76 | ₹15.90 | ₹7.61 | ₹12.64 |
| Total Revenue | ₹369.05 | ₹344.87 | ₹282.66 | ₹331.31 |
| Total Expenses | ₹345.17 | ₹294.17 | ₹256.07 | ₹262.33 |
| Profit Before Tax | ₹23.88 | ₹50.71 | ₹26.60 | ₹68.97 |
| Tax | ₹5.75 | ₹12.19 | ₹6.48 | ₹16.73 |
| Profit After Tax | ₹18.13 | ₹38.52 | ₹20.12 | ₹52.25 |
| EPS - Basic | ₹29.35 | ₹62.35 | ₹32.57 | ₹84.57 |
| EPS - Diluted | ₹29.35 | ₹62.35 | ₹32.57 | ₹84.57 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹23.88 | ₹50.71 | ₹26.60 | ₹68.97 |
| Income before WC changes | ₹32.59 | ₹49.58 | ₹32.51 | ₹75.60 |
| Change in Assets | -₹25.99 | -₹51.94 | ₹18.04 | -₹51.10 |
| Change in Liabilities | ₹16.17 | ₹25.68 | -₹12.18 | ₹4.91 |
| Change in WC | -₹9.82 | -₹26.26 | ₹5.86 | -₹46.19 |
| Cash flow from Operations | ₹17.02 | ₹11.14 | ₹31.89 | ₹12.69 |
| Cash flow from Investing | -₹15.75 | -₹17.49 | -₹23.62 | -₹13.00 |
| Cash flow from Financing | -₹1.08 | -₹1.08 | -₹1.08 | -₹1.08 |
| Total Cash Flow | ₹0.19 | -₹7.44 | ₹7.19 | -₹1.40 |
| Cash (Start of the year) | ₹0.39 | ₹7.82 | ₹0.64 | ₹2.03 |
| Cash (End of the year) | ₹0.57 | ₹0.39 | ₹7.82 | ₹0.64 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹195.89 | ₹149.35 | ₹128.92 | ₹107.68 |
| Current Assets | ₹229.87 | ₹203.69 | ₹159.19 | ₹170.04 |
| Total Assets | ₹425.76 | ₹353.05 | ₹288.11 | ₹277.72 |
| Current Liabilities | ₹114.61 | ₹84.36 | ₹56.65 | ₹63.12 |
| Net Current Asset | ₹115.27 | ₹119.33 | ₹102.54 | ₹106.92 |
| Non-Current Liabilities | ₹31.54 | ₹5.88 | ₹5.94 | ₹8.03 |
| Equity Capital | ₹279.61 | ₹262.81 | ₹225.52 | ₹206.56 |
| Total Equity & Liabilities | ₹425.76 | ₹353.05 | ₹288.11 | ₹277.72 |
About NGL Fine Chem
NGL Fine-Chem Limited is an India-based company, which is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health. The Company caters to various global companies to custom manufacture pharmaceuticals. Its products include APIs Animal Health, APIs Human Health, Intermediates and Specialty Chemicals and Finished Dosage Form. The APIs Animal Health products include Homidium Chloride, Nitroxynil, Clorsulon, Parvaquone, Buparvaquone, Isometamidium Chloride Hydrochloride, Toldimfos Sodium, Butaphosphan, Imidocarb Dipropionate, Triclabendazole, Rafoxanide, Diminazene Aceturate, S-Methoprene, Carprofen and others. The APIs Human Health products include Nitazoxanide and Atovaquone. The Intermediates and Specialty Chemicals product includes 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-Ethyl Glucamine. The Finished Dosage Form products include Diminazene Aceturate Granules and Homidium Chloride Tablets. It has manufacturing plants located around Mumbai.
NGL Fine Chem Financial Highlights
- Revenue: NGL Fine Chem reported revenue of ₹515.68 crore in FY26 vs ₹376.89 crore in FY25. It showed an increase of 36.83% on a yearly basis.
- Operating Profit: NGL Fine Chem reported an operating profit of ₹63.37 crore in FY26 vs ₹27.71 crore in FY25. It showed an increase of 128.69% on a year-on-year basis.
- Net Profit: NGL Fine Chem reported a net profit of ₹48.13 crore in FY26 vs ₹21.12 crore in FY25. It showed an increase of 127.89% on a yearly basis.
NGL Fine Chem Quarterly Result Highlights
- NGL Fine Chem reported revenue of ₹151.69 crore in Mar 2026, compared with ₹132.12 crore in Dec 2025, representing an increase of 14.81% on a quarter-on-quarter (QoQ) basis.
- NGL Fine Chem reported an operating profit of ₹17.81 crore in Mar 2026, compared with ₹20.67 crore in Dec 2025, representing a decrease of 13.84% on a quarter-on-quarter (QoQ) basis.
- NGL Fine Chem reported a profit of ₹13.49 crore in Mar 2026, compared with ₹15.69 crore in Dec 2025, reflecting a decrease of 14.02% on a QoQ basis.
- The earnings per share (EPS) of NGL Fine Chem stood at ₹34.19 during Mar 2026.
Similar Stocks
FAQs on NGL Fine Chem Share Price
What is NGL Fine Chem share price today?
NGL Fine Chem share price is ₹3,206.00 as on 03 Jul, 2026, 15:49 IST.
How has the NGL Fine Chem share price performed in the past?
In the last 1 year, NGL Fine Chem delivered a return of 164.94%. The NGL Fine Chem share price hit a high of ₹3,260.00 and low of ₹1,175.50.
How much is the Mutual Fund shareholding in NGL Fine Chem shares?
The Mutual Fund Shareholding in NGL Fine Chem was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of NGL Fine Chem shares ?
The 52-week high and low of NGL Fine Chem share is ₹3,260.00 and ₹1,175.50 as of 03 Jul, 2026.
What is the market cap of NGL Fine Chem?
The market capitalisation of NGL Fine Chem is ₹1,815.34 Crores as on 03 Jul, 2026.
What are the stock symbols of NGL Fine Chem?
The stock symbol of NGL Fine Chem is NGLFINE on the NSE, 524774 on the BSE, and the ISIN is INE887E01022.
What was yesterday's closing price of NGL Fine Chem shares ?
NGL Fine Chem shares closed yesterday at ₹2,937.60 on NSE & ₹2,937.45 on BSE
How to buy NGL Fine Chem shares?
To buy NGL Fine Chem shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy NGL Fine Chem shares on Holidays?
No, shares of NGL Fine Chem or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell NGL Fine Chem shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of NGL Fine Chem?
The PE and PB ratio of NGL Fine Chem is 37.72 and 5.51 respectively, as on 03 Jul, 2026, 15:49 IST.